AB
AMPH icon

Amalgamated Bank’s Amphastar Pharmaceuticals AMPH Stock Holding History

Amalgamated Bank’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,215
Closed -$200K – 1635
2026
Q1 		$200K Sell
10,215
-204
-2% -$4.99K ﹤0.01% 1563
2025
Q4 		$279K Sell
10,419
-75
-0.7% -$1.93K ﹤0.01% 1491
2025
Q3 		$280K Sell
10,494
-55
-0.5% -$1.42K ﹤0.01% 1482
2025
Q2 		$242K Sell
10,549
-212
-2% -$5.26K ﹤0.01% 1504
2025
Q1 		$312K Sell
10,761
-237
-2% -$7.57K ﹤0.01% 1417
2024
Q4 		$408K Sell
10,998
-278
-2% -$12.7K ﹤0.01% 1364
2024
Q3 		$547K Sell
11,276
-205
-2% -$9K ﹤0.01% 1266
2024
Q2 		$459K Sell
11,481
-137
-1% -$5.68K ﹤0.01% 1328
2024
Q1 		$510K Sell
11,618
-4,726
-29% -$244K ﹤0.01% 1306
2023
Q4 		$1.01M Sell
16,344
-578
-3% -$30.4K 0.01% 1167
2023
Q3 		$778K Sell
16,922
-357
-2% -$19.5K 0.01% 1216
2023
Q2 		$993K Buy
17,279
+58
+0.3% +$2.57K 0.01% 1133
2023
Q1 		$646K Sell
17,221
-1,188
-6% -$38.9K 0.01% 1310
2022
Q4 		$516K Sell
18,409
-168
-0.9% -$4.88K ﹤0.01% 1449
2022
Q3 		$522K Buy
18,577
+371
+2% +$12.1K 0.01% 1413
2022
Q2 		$633K Buy
18,206
+1,297
+8% +$46.3K 0.01% 1354
2022
Q1 		$607K Sell
16,909
-1,024
-6% -$29K ﹤0.01% 1465
2021
Q4 		$418K Buy
17,933
+213
+1% +$4.36K ﹤0.01% 1662
2021
Q3 		$337K Sell
17,720
-291
-2% -$5.7K ﹤0.01% 1792
2021
Q2 		$363K Buy
+18,011
New +$339K ﹤0.01% 1796

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Amalgamated Bank's AMPH Position: Q2 2026 in Review

Amalgamated Bank sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2026, closing a stake of 10,215 shares — an estimated $200K sold.

Amalgamated Bank first reported a position in AMPH in Q2 2021 and held it in 20 quarters. The position peaked at $1.01M in Q4 2023. 212 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Amalgamated Bank reported no remaining Amphastar Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Amalgamated Bank sold 10,215 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $200K.
  • Amalgamated Bank first reported a position in Amphastar Pharmaceuticals in Q2 2021 and held it in 20 quarters.
  • Amalgamated Bank's Amphastar Pharmaceuticals position peaked at $1.01M in Q4 2023.
  • 212 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.